Jahnel U, Jakob H, Nawrath H
Pharmakologisches Institut, Universität Mainz, Federal Republic of Germany.
Naunyn Schmiedebergs Arch Pharmacol. 1992 Jul;346(1):82-7. doi: 10.1007/BF00167575.
The effects of alpha-adrenoceptor stimulation on force of contraction were investigated in human atrial heart muscle and compared with those of beta-adrenoceptor stimulation. The maximal positive inotropic effect produced by stimulation of alpha-adrenoceptors with phenylephrine (in the presence of atenolol 10 mumol/l) was significantly smaller than that seen in response to beta-adrenoceptor stimulation with isoprenaline. The maximal effect of phenylephrine (25% of the maximal effect of isoprenaline) required far higher concentrations (1 mmol/l) than isoprenaline (100 nmol/l); the EC50 values amounted to 33.1 mumol/l and 3.3 nmol/l, respectively. In the presence of the alpha-adrenoceptor blocking agent phentolamine (1 mumol/l), the concentration-response curve of phenylephrine was displaced to higher concentrations of the agonist; under these conditions, the EC50 value amounted to 52.5 mumol/l. The effects of the catecholamines noradrenaline and adrenaline on force of contraction remained unchanged in the presence of phentolamine (1 mumol/l) or prazosin (1 mumol/l). The positive inotropic effect of phenylephrine (1 mmol/l) was associated with a slight decrease in action potential duration; the effects on action potential were completely blocked in the presence of phentolamine (1 mumol/l). These findings support the view that selective stimulation of alpha-adrenoceptors may mediate a small but detectable positive inotropic effect in human atrial tissue under in vitro conditions. The requirement of high concentrations of alpha-adrenoceptor agonists and the lack of effects of the endogenous catecholamines adrenaline and noradrenaline on alpha-adrenoceptors (in concentrations which fully elicit the beta-adrenoceptors-mediated response) do not provide a basis for a functional role of alpha-adrenoceptor-mediated effects under in vivo conditions.(ABSTRACT TRUNCATED AT 250 WORDS)
在人心房肌中研究了α-肾上腺素能受体刺激对收缩力的影响,并与β-肾上腺素能受体刺激的影响进行了比较。用去氧肾上腺素刺激α-肾上腺素能受体(在10 μmol/l阿替洛尔存在下)产生的最大正性肌力作用明显小于用异丙肾上腺素刺激β-肾上腺素能受体时所见的作用。去氧肾上腺素的最大作用(异丙肾上腺素最大作用的25%)所需浓度(1 mmol/l)远高于异丙肾上腺素(100 nmol/l);EC50值分别为33.1 μmol/l和3.3 nmol/l。在α-肾上腺素能受体阻断剂酚妥拉明(1 μmol/l)存在下,去氧肾上腺素的浓度-反应曲线向更高浓度的激动剂方向移动;在这些条件下,EC50值为52.5 μmol/l。在酚妥拉明(1 μmol/l)或哌唑嗪(1 μmol/l)存在下,儿茶酚胺去甲肾上腺素和肾上腺素对收缩力的作用保持不变。去氧肾上腺素(1 mmol/l)的正性肌力作用与动作电位持续时间略有缩短有关;在酚妥拉明(1 μmol/l)存在下,对动作电位的作用完全被阻断。这些发现支持这样一种观点,即在体外条件下,选择性刺激α-肾上腺素能受体可能介导人心房组织中一种小但可检测到的正性肌力作用。高浓度α-肾上腺素能受体激动剂的需求以及内源性儿茶酚胺肾上腺素和去甲肾上腺素对α-肾上腺素能受体无作用(在完全引发β-肾上腺素能受体介导反应的浓度下),这并不能为α-肾上腺素能受体介导的作用在体内条件下的功能作用提供依据。(摘要截短于250字)